To assess the expression of four hypoxia-related hub genes (ADM, PPFIA4, FAM162A and TPBG) between CAD patients and the control population, qRT‒PCR was used to quantify mRNA expression levels. The gene discussed is FAM162A; the disease is coronary artery disorder.